Silexion Therapeutics Receives Approval from Israeli Ministry of Well being to Begin Segment 2/3 Medical Trial of SIL204 in In the community Complicated Pancreatic Most cancers
Important regulatory milestone marks development into clinical-stage building of next-generation RNAi remedy…
